Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 50090-7942

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 50090-7942). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907942)

Venlafaxine Hydrochloride 150 mg extended-release oral capsules, labeled as containing 30 capsules per package. The label displays the product name, dosage form, strength, manufacturer as A-S Medication Solutions, Libertyville, IL 60048, and storage conditions (store at 68 to 77 degrees F). A barcode and NDC number 50090-7942 are also visible.*

FDA Label Image

Figure (Venlafaxine Fig1)

A scatter plot chart illustrating fold changes and 90% confidence intervals for pharmacokinetic parameters (Cmax, AUC) of venlafaxine and its ODV metabolite under various special population conditions including hepatic impairment, renal impairment, CYP2D6 metabolizer status, age over 60, and gender differences. The x-axis shows the change relative to a reference value, highlighting variability in drug exposure among these groups.*

FDA Label Image

Figure (Venlafaxine Fig2)

A scatter plot chart showing the fold change and 90% confidence interval for venlafaxine pharmacokinetic parameters (Cmax and AUC) after interaction with various drugs, including ethanol, diazepam, cimetidine, ketoconazole in CYP2D6 EMs and PMs, indinavir, metoprolol, imipramine, and lithium. The x-axis represents change relative to the reference value, with data points indicating increases or decreases in drug exposure.*

FDA Label Image

Figure (Venlafaxine Fig3)

A forest plot chart showing fold changes and 90% confidence intervals in pharmacokinetic parameters (Cmax and AUC) for various analytes of interacting drugs relative to a reference value. Drugs listed include ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium, with corresponding fold changes plotted on a horizontal axis from 0 to 3.*

FDA Label Image

Chemical Structure (Venlafaxine Str)

Chemical structure of venlafaxine hydrochloride showing its molecular components including a cyclohexanol group, methoxyphenyl group, and a dimethylaminoethyl side chain with the hydrochloride salt.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.